Promethera Biosciences makes progress in HepaStem development programme

Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...

May 9, 2019 | Thursday | News
WISE enrolls first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring

WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation,...

May 8, 2019 | Wednesday | News
AstraZeneca’s Calquence phase III ASCEND trial meets positive result

AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treate...

May 8, 2019 | Wednesday | News
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response

Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...

May 8, 2019 | Wednesday | News
Innovent Biologics, Eli Lilly has announced that IBI301 has met pre-defined primary endpoints

Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...

May 8, 2019 | Wednesday | News
VolitionRx initiates clinical trial programme in lung cancer

US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...

May 8, 2019 | Wednesday | News
Clinical research is becoming more disintegrated with the influx of data from different sources

Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...

May 7, 2019 | Tuesday | Opinion
Tessa Therapeutics, Baylor College of Medicine present results for the treatment of HER2-positive solid tumors

Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide rang...

May 3, 2019 | Friday | News
NMPA approves Sinovant's clinical trial application for Derazantinib

Sinovant Sciences has announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the...

April 30, 2019 | Tuesday | News
ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD

ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative ...

April 26, 2019 | Friday | News
CMD LLC wins AU$1 million grant award from FightMND

Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...

April 18, 2019 | Thursday | News
Zydus Cadila announces phase III trial of Desidustat

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Inve...

April 17, 2019 | Wednesday | News
CStone Pharmaceuticals announces dosing in Ph III trial for treating adenocarcinoma

CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinic...

April 16, 2019 | Tuesday | News
CStone receives IND approval in China for avapritinib study

CStone Pharmaceuticals has announced that the National Medical Products Administration (NMPA) recently approved the init...

April 15, 2019 | Monday | News
I-Mab Biopharma collaborates with Roche for combination therapy

I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential ...

April 11, 2019 | Thursday | News
George Clinical establishes new presence in Singapore

George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in ...

April 10, 2019 | Wednesday | News
NIH begins first-in-human trial of a universal influenza vaccine candidate

The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety ...

April 5, 2019 | Friday | News
Veeda Clinical Research Achieves ISO 27001:2013 Certification

India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has award...

April 3, 2019 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls